“cell-therapeutics” Archives

Entry Author Date Location
UT Health Cancer Center Hires Rare Blood Cancer Expert as Director 06/15/17 Texas
Drug Discovery in Seattle 2015: An Updated History 08/03/15 Seattle
CTI Goes Up, And Down, And Back Up On Phase 3 Myelofibrosis News 03/09/15 Seattle
Promedior Sees Hope in Small Myelofibrosis Study 05/30/14 Boston
Cell Therapeutics Shells Out $30M for New Drug 04/19/12 Seattle
Cell Therapeutics Stock Rises on EU Recommendation for Lymphoma Drug 02/17/12 Seattle
Cell Therapeutics Pulls FDA Application, Saying It Isn’t Ready For Panel 01/30/12 Seattle
The Year in Seattle Biotech: Lots of Acquisitions, Few New Startups 12/22/11 Seattle
Theraclone Nabs Big Pfizer Deal, Dendreon Pockets $540M, Seattle Genetics’ Close-Up, & More Seattle-Area Life Sciences News 01/20/11 Seattle
Cell Therapeutics Snags $25M 01/13/11 Seattle
Cell Therapeutics Seeks EU Approval 11/01/10 Seattle
Intellectual Ventures’ Med-Tech Foray, PATH Takes Ultra Rice to Africa, Mirador Gets FDA OK, & More Seattle-Area Life Sciences News 10/21/10 Seattle
Cell Therapeutics Adds $21M 10/20/10 Seattle
Lee Hartwell’s Next Career Move, Swedish’s Social Media Ace, Cell Therapeutics’ Lifeline, & More Seattle-Area Life Sciences News 09/23/10 Seattle
Cell Therapeutics Finds Way to Survive, Persuading Investors to OK Sale of 400M Shares 09/16/10 Seattle
Biotech Drug Discovery in Seattle: A Look Back 06/11/10 Seattle
Seattle Genetics Grows Up Fast, Valocor Seeks to Fight Acne, Cell Therapeutics Nabs $21M & More Seattle-Area Life Sciences News 05/27/10 Seattle
Cell Therapeutics Adds $21M 05/24/10 Seattle
AVI Biopharma Ousts CEO, CombiMatrix Drops Seattle Wing, Cell Therapeutics Cans 36 Workers, & More Seattle-Area Life Sciences News 04/22/10 Seattle
Cell Therapeutics Cuts 36 Employees 04/15/10 Seattle
Dendreon’s Pricing Question, UW’s $300M Stimulus Windfall, Cell Therapeutics Rejected by FDA, & More Seattle-Area Life Sciences News 04/15/10 Seattle
Cell Therapeutics Shareholder Meeting Postponed, After FDA Rejection 04/09/10 Seattle
Cell Therapeutics Lymphoma Drug Fails to Win FDA Approval 04/09/10 Seattle
Our Top 20 Stories of the First Quarter: Amazon, Cell Therapeutics, Dendreon, Microsoft, and More 04/02/10 Seattle
FDA Panel Slams Cell Therapeutics, Oncothyreon Slumps, Biotech’s Healthcare Victory, & More Seattle-Area Life Sciences News 03/25/10 Seattle
Cell Therapeutics Looks to Pick up the Pieces After FDA Smacks Down Lymphoma Drug 03/23/10 Seattle
Cell Therapeutics Shares Crash as Lymphoma Drug Gets Shot Down by FDA Panel 03/22/10 Seattle
FDA Cancer Drug Boss Slams Cell Therapeutics Application For Lymphoma Drug 03/22/10 Seattle
Cell Therapeutics FDA Panel Primer: Take Two 03/19/10 Seattle
Cell Therapeutics Passes Factory Test 03/08/10 Seattle
Page 1 of 4 next page »